This design allowed us to rapidly discover and validate eight proteins, namely p53, ETHE1, CTAG1A, C1QTNF1, TEX264, CLDN2, NSG1, and HRas, as biomarkers for LC early diagnosis. Here, TP53 is linked to laryngotracheoesophageal cleft.